Clinical Trial Update: Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability and food-effect study of GSK163090 in healthy volunteers to characterize pharmacokinetics and potential food interactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Depressive Disorder

Drugs mentioned

• GSK163090

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder and Anxiety Disorders | Phase 1 | Status: COMPLETED